Bank of New York Mellon Corp decreased its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 5.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 155,288 shares of the industrial products company's stock after selling 8,967 shares during the quarter. Bank of New York Mellon Corp owned about 0.65% of Proto Labs worth $5,441,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the business. Dimensional Fund Advisors LP grew its position in shares of Proto Labs by 5.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,300,864 shares of the industrial products company's stock worth $50,851,000 after buying an additional 68,006 shares during the period. First Trust Advisors LP grew its holdings in Proto Labs by 71.9% during the fourth quarter. First Trust Advisors LP now owns 738,576 shares of the industrial products company's stock valued at $28,871,000 after purchasing an additional 308,970 shares during the period. Renaissance Technologies LLC grew its holdings in Proto Labs by 2.7% during the fourth quarter. Renaissance Technologies LLC now owns 571,851 shares of the industrial products company's stock valued at $22,354,000 after purchasing an additional 15,000 shares during the period. S Squared Technology LLC grew its holdings in Proto Labs by 5.1% during the fourth quarter. S Squared Technology LLC now owns 307,003 shares of the industrial products company's stock valued at $12,001,000 after purchasing an additional 15,000 shares during the period. Finally, Northern Trust Corp grew its holdings in Proto Labs by 3.4% during the fourth quarter. Northern Trust Corp now owns 281,639 shares of the industrial products company's stock valued at $11,009,000 after purchasing an additional 9,314 shares during the period. Institutional investors and hedge funds own 84.54% of the company's stock.
Proto Labs Stock Up 0.8%
NYSE PRLB traded up $0.31 during trading on Friday, reaching $39.05. 104,588 shares of the stock traded hands, compared to its average volume of 169,348. Proto Labs, Inc. has a fifty-two week low of $25.75 and a fifty-two week high of $46.73. The stock's 50-day moving average price is $39.14 and its 200 day moving average price is $38.44. The firm has a market cap of $928.22 million, a price-to-earnings ratio of 65.08 and a beta of 1.33.
Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The industrial products company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.04. Proto Labs had a net margin of 2.99% and a return on equity of 2.22%. The firm had revenue of $126.21 million for the quarter, compared to analyst estimates of $123.71 million. During the same quarter in the previous year, the firm posted $0.40 earnings per share. The business's revenue was down 1.3% on a year-over-year basis. Analysts anticipate that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Tuesday, May 6th.
Get Our Latest Stock Report on Proto Labs
Proto Labs Profile
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Stories

Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.